Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin

por Andersson, Y, Engebraaten, O, Juell, S, Aamdal, S, Brunsvig, P, Fodstad, Ø, Dueland, S
Publicado 2015

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity

por Helbekkmo, N, Sundstrøm, S H, Aasebø, U, Fr Brunsvig, P, von Plessen, C, Hjelde, H H, Garpestad, O K, Bailey, A, Bremnes, R M
Publicado 2007

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma

por Nyakas, M., Aamdal, E., Jacobsen, K. D., Guren, T. K., Aamdal, S., Hagene, K. T., Brunsvig, P., Yndestad, A., Halvorsen, B., Tasken, K. A., Aukrust, P., Mælandsmo, G. M., Ueland, T.
Publicado 2019